Yi-Wei Xu (Yiwei Xu)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Topics

Systemic Lupus Erythematosus

Binding Protein

Systematic Review

Top Venues

Disease markers

Cancer medicine

Bioscience reports

This page only lists publications with an associated author ORCID identifier.

Publications

Biao Zhang, Yu-Hui Peng, Yun Luo, Chao-Qun Hong, Yi-Wei Lin, Yu-Ling Zhang, Yi-Wei Xu, Xue-Fen Su, Fang-Cai Wu
Relationship between esophageal squamous cell carcinoma risk and alcohol-related ALDH2 and ADH1B polymorphisms: Evidence from a meta-analysis and Mendelian randomization analysis. Cancer medicine (2023)
Biao Zhang, Chao-Qun Hong, Yu-Hao Luo, Lai-Feng Wei, Yun Luo, Yu-Hui Peng, Yi-Wei Xu
Prognostic value of IGFBP2 in various cancers: a systematic review and meta-analysis. Cancer medicine 11 (16) (2022)
Yin-Qiao Liu, Ling-Yu Chu, Tian Yang, Biao Zhang, Zheng-Tan Zheng, Jian-Jun Xie, Yi-Wei Xu, Wang-Kai Fang
Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. Bioscience reports 42 (5) (2022)
Ling-Yu Chu, Jian-Yuan Zhou, Yi-Xuan Zhao, Yan-Ting Ou, Tian Yang, Yu-Hui Peng, Wang-Kai Fang, Yi-Wei Xu, Jian-Jun Xie
Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor. Bioscience reports 41 (6) (2022)
Lai-Feng Wei, Xu-Chun Huang, Yi-Wei Lin, Yun Luo, Tian-Yan Ding, Can-Tong Liu, Ling-Yu Chu, Yi-Wei Xu, Yu-Hui Peng, Hai-Peng Guo
A Prognostic Model Based on Clinicopathological Features and Inflammation- and Nutrition-Related Indicators Predicts Overall Survival in Surgical Patients With Tongue Squamous Cell Carcinoma. Technology in cancer research & treatment 20 (2022)
Shi-Han Yang, Can-Tong Liu, Chao-Qun Hong, Ze-Yuan Huang, Huan-Zhu Wang, Lai-Feng Wei, Yi-Wei Lin, Hai-Peng Guo, Yu-Hui Peng, Yi-Wei Xu
Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers. Disease markers 2021 (2021)
Zheng Li, Haijie Xu, Jiaming Yu, Cantong Liu, Chunwen Zheng, Ruijie Zeng, Liyan Xu, Enmin Li, Yuhui Peng, Yi-Wei Xu
The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma. Cancer control : journal of the Moffitt Cancer Center 28 (2021)
Tianyan Ding, Cantong Liu, Binliang Huang, Ling-Yu Chu, Laifeng Wei, Yiwei Lin, Yun Luo, Biao Zhang, Chaoqun Hong, Yi-Wei Xu, Yuhui Peng
A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery. Cancer management and research 13 (2021)
Can-Tong Liu, Yi-Wei Xu, Hong Guo, Chao-Qun Hong, Xin-Yi Huang, Yu-Hao Luo, Shi-Han Yang, Ling-Yu Chu, En-Min Li, Yu-Hui Peng
Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma. Gut and liver 14 (6) (2021)
Bo Qiu, Ling-Yu Chu, Xin-Xin Li, Yu-Hui Peng, Yi-Wei Xu, Jian-Jun Xie, Xiao-Yang Chen
Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer. OncoTargets and therapy 13 (2020)
Hao Chen, Qiaohua Zhong, Xiaobin Wu, Yanling Ding, Qi Chen, Ning Xue, Yi-Wei Xu, Shulin Chen
Preliminary evaluation of a candidate international reference for Epstein-Barr virus capsid antigen immunoglobulin A in China. Infectious agents and cancer 15 (2020)
Yi-Wei Xu, Can-Tong Liu, Xin-Yi Huang, Li-Sheng Huang, Yu-Hao Luo, Chao-Qun Hong, Hai-Peng Guo, Li-Yan Xu, Yu-Hui Peng, En-Min Li
Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma. Disease markers 2017 (2017)
Lan Li, Ming Liu, Jian-Bang Lin, Xin-Bin Hong, Wen-Xia Chen, Hong Guo, Li-Yan Xu, Yi-Wei Xu, En-Min Li, Yu-Hui Peng
Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma. Disease markers 2017 (2017)